<- Go Home
European Biotech Acquisition Corp.
As of March 2, 2023, European Biotech Acquisition Corp. was acquired by Oculis Holding AG, in a reverse merger transaction.European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on business in the life sciences industry in Europe. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Market Cap
$183.5M
Volume
28.7K
Cash and Equivalents
$308.5K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$14.10
52 Week Low
$9.28
Dividend
N/A
Price / Book Value
-22.77
Price / Earnings
654.08
Price / Tangible Book Value
-22.77
Enterprise Value
$183.2M
Enterprise Value / EBITDA
N/A
Operating Income
-$2.8M
Return on Equity
4.65%
Return on Assets
-1.36
Cash and Short Term Investments
$308.5K
Debt
N/A
Equity
-$8.1M
Revenue
N/A
Unlevered FCF
-$1.5M
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium